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Abstract: The present study aimed to evaluate the impact of The Trivedi Effect®- Energy of Consciousness Healing 
Treatment based new proprietary herbomineral formulation and Energy Healing Treatment per se in male Sprague Dawley rats 
for immune biomarkers modulation. The test formulation was divided into two parts, one as the control without any Biofield 
Energy Treatment, while the other part was defined as the Biofield Energy Treated sample, which received the Biofield Energy 
Healing Treatment remotely from seven renowned Biofield Energy Healers. Additionally, one group of animals also received 
Biofield Energy Treatment per se (day -15) by under similar conditions. Humoral immune response data showed an increased 
level of IgG by 2.89%, 6.20%, and 6.20% in the Biofield Energy Treated test formulation group (G4), Biofield Energy 
Treatment group per se (G6), and Biofield Energy Treated test formulation at day -15 (G7), respectively as compared with the 
disease control group (G2). The ratio of CD4
+
/CD8
+
 was increased by 3.80%, 12.38%, and 16.19% in the G4, G6, and G7, 
respectively compared with the G2. Hematology analysis suggested an increased level of TLC and neutrophil by 9.64% and 
1.48%, respectively in the G4 group, while G6 group showed an increase count of TLC, lymphocytes, and monocytes by 
19.79%, 2.87%, and 15.54%, respectively compared with the G2. Biochemical study showed an increased concentration of 
glucose by 11.78%, 18.60%, and 56.84% in the G4, G6, and G7, respectively compared with G2. Total cholesterol was 
significantly decreased by 10.54% and 4.20% in the G4 and G7, respectively compared with G2. In contrast, the HDL level 
was increased by 11.69% and 1.06% in G6 and G7, respectively while LDL was decreased by 10.52% in G4 compared with 
the G2. SGOT, CK-MB, total protein, albumin, and globulin levels were decreased by 4.04%, 23.54%, 1.68%, 1.54%, and 
1.80%, respectively in G4, while G6 group showed decreased level of SGOT, CK-MB, and A/G ratio by 2.08%, 16.23%, and 
3.40%, respectively compared with G2. However, SGOT was significantly decreased (p≤0.01) by 18.88% in G7 compared 
with G2. The testosterone level was decreased by 76.67%, 18.43%, and 44.06% in G4, G6, and G7, respectively compared 
with G2. Antioxidant profile showed a decreased level of LPO by 59.63% in G7, while SOD and CAT levels were significantly 
altered in tested groups compared with G2. Biofield Energy may also be used for autoimmune and inflammatory diseases, 
stress management and prevention, and anti-aging by improving overall health. 
Keywords: Biofield Energy Healing Treatment, Consciousness Energy Healing Treatment, The Trivedi Effect®, 
Herbomineral Formulation, Anti-oxidation, Autoimmunity, Anti-Aging, Alzheimer’s Disease 
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1. Introduction 
Herbomineral products have been accepted worldwide 
against many health related disorders, due to their significant 
immunomodulatory potential. However, the action of 
herbominerals as an immune booster make it unique as 
compared with other available nutraceutical products. 
Overall quality of life (QoL) can be improved by maintaining 
the organic resistance of the body. It was reported that 
secondary metabolites of plants extract and minerals play an 
important role in immunomodulatory action [1-3]. Herbal 
medicines and minerals are the major targeted product to 
modulate the immune system due to its low toxicity profile 
compared with the synthetic drugs against infections [4, 5]. 
However, as a conventional approach, immunomodulatory 
therapy has now been considered as primary treatment in 
many disease conditions. To predict the severity of infection 
and evaluating the therapeutic immunomodulatory potential 
of any herbomineral formulations, biomarkers with respect to 
hepatic, cardiac, lipid, hematology, cellular and humoral 
response are considered as the standard method of analysis 
[6]. According to the scientific literatures, and as per the best 
medicinal activity of herbal extract, a new proprietary 
herbomineral formulation was formulated with a combination 
of the herb ashwagandha (Withania somnifera) root extract 
and three minerals viz. zinc, magnesium, and selenium. All 
the ingredients of the formulation in this present study 
possess important activities such as immune-modulatory, 
anti-inflammatory, antioxidant, anti-infective, and anti-viral 
properties [7-9]. 
Ashwagandha biological activity is mainly reported due to 
the presence of withanolides, and it is used as complementary 
medicine in alternative therapies. Apart from its common 
attributes such as antibacterial, immunomodulatory and 
antitumor effects, many clinical and preclinical data have 
been available with respect to the immunomodulatory impact 
[10, 11]. The importance of minerals such as selenium, zinc, 
and magnesium is to modulate the immune system because 
their synergistic impact has been well-defined. Zinc regulates 
most of the biochemical reaction in the living organism 
because of enzyme catalyzing activity, while selenium work 
as significant immunomodulatory effect by altering the CD8
+
 
lymphocyte function. Similarly, magnesium is also 
responsible for cytokine production through NF-κB pathways 
activation, a novel innate immunomodulatory mechanism 
[12-15]. 
Scientific research has been reported that the combination 
of minerals and herbal medicines have been found to exhibit 
significant immunomodulatory action [5]. Herbomineral 
formulations can be used for better therapeutic effect in 
immune compromised patients that are affected by the 
cardiovascular diseases, age, stress related diseases, cancer, 
and autoimmune disorders. Along with the herbomineral 
formulations, the Biofield Energy Healers in this study have 
used Energy Medicine (Biofield Energy Healing Treatment) 
as a complementary and alternative approach to study the 
impact of the Biofield Energy Treatment on the herbomineral 
formulation for its immunomodulatory potential in male 
Sprague Dawley rats. 
Amidst many Complementary and Alternative Medicine 
(CAM) therapies, there have been an extensive number of 
scientific reports that showed Biofield Therapy (or Healing 
Modalities) as preferred models of treatment with several 
benefits to enhance physical, mental and emotional human 
wellness. The National Center of Complementary and 
Integrative Health (NCCIH) has recognized and accepted 
Biofield Energy Healing as a CAM health care approach in 
addition to other therapies, medicines and practices such as 
natural products, deep breathing, yoga, Tai Chi, Qi Gong, 
chiropractic/osteopathic manipulation, meditation, massage, 
special diets, homeopathy, progressive relaxation, guided 
imagery, acupressure, acupuncture, relaxation techniques, 
hypnotherapy, healing touch, movement therapy, pilates, 
Rolfing structural integration, mindfulness, Ayurvedic 
medicine, traditional Chinese herbs and medicines, 
naturopathy, essential oils, aromatherapy, Reiki, and cranial 
sacral therapy. Human Biofield Energy has subtle energy that 
has the capacity to work in an effective manner [16]. CAM 
therapies have been practiced worldwide with reported 
clinical benefits in different health disease profiles [17]. 
Biofield Energy Healing Treatment has gained rapid rapport 
as a holistic alternative and complementary medicine therapy 
that has a significant impact on living organisms and 
nonliving materials without any adverse effects and in a 
manner that is more cost-effective than more conventional 
methods. Biofield Energy Treatment (The Trivedi Effect
®
) 
results has been published in numerous peer-reviewed 
science journals with significant outcomes in many scientific 
fields such as cancer research [18], microbiology [19-21], 
genetics [22, 23], pharmaceutics [24, 25], nutraceuticals [26], 
organic compounds [27, 28], agricultural science [29, 30], 
and changing the structure of the atom in relation to various 
metals, ceramics, polymers and chemicals in materials 
science [31-33]. 
In this study, the authors sought to explore the impact of 
the Biofield Energy Treatment (The Trivedi Effect
®
) on the 
given herbomineral formulation and Biofield Energy 
Treatment per se to the animals, which might improve the 
immunomodulatory function in cyclophosphamide induced 
immunosuppression in male Sprague Dawley rat model by 
identification of various immunity biomarkers. 
2. Materials and Methods 
2.1. Chemicals and Reagents 
The chemicals such as pyrogallol and carboxymethyl 
cellulose sodium were purchased from Sigma Chemical Co. 
(St. Louis, MO). Ashwagandha (Withania somnifera) root 
extract powder (≥5% of total withanolides) was procured 
from Sanat Products Ltd., India. Zinc chloride and 
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magnesium (II) gluconate hydrate were procured from TCI, 
Japan. Sodium selenate was procured from Alfa Aesar, USA. 
Levamisole hydrochloride was procured from Sigma, USA. 
All other chemicals used were of analytical grade available in 
India. 
2.2. Experimental Animals 
A total number of 56 healthy male Sprague Dawley rats, 
weighing between 220-250 grams, were used for the study 
(n=8, in each group). The animals were purchased from M/s. 
Vivo Bio Tech Ltd., Hyderabad, India. Standard rodent diet 
was procured from M/s. Golden feeds, Mehrauli, New Delhi, 
India and provided ad libitum to all the groups of animals 
during the experiment under controlled conditions with a 
temperature of 22 ± 3°C, humidity of 30% to 70% and a 12-
hour light/12-hour dark cycle. The animals were acclimatized 
for 5 days prior to the experiment, and all were accessed once 
daily for clinical signs, behaviors, morbidity and mortality. 
All the procedures were in strict accordance with the Guide 
for the Care and Use of Laboratory Animals published by the 
US National Institutes of Health. The approval of the 
Institutional Animal Ethics Committee that was obtained 
prior to carrying out the animal experiment. 
2.3. Energy of Consciousness Treatment Strategies 
The test formulation was divided into two parts. One part 
of the test formulation was treated with the Biofield Energy 
by renowned Biofield Energy Healers (also known as The 
Trivedi Effect
®
) and coded as the Biofield Energy Treated 
formulation, while the second part of the test formulation 
did not receive any sort of treatment and was defined as the 
untreated test formulation. This Biofield Energy Treatment 
was provided through a group of seven Biofield Energy 
Healers who participated in this study and performed the 
Biofield Energy Treatment remotely. Six Biofield Energy 
Healers were remotely located in the U.S.A. and one was 
located in Canada, while the test herbomineral formulation 
was located in the research laboratory of Dabur Research 
Foundation, New Delhi, India. Additionally, one group of 
animals also received the Biofield Energy Treatment per se 
by the Biofield Energy Healers under similar conditions. 
This Biofield Energy Treatment was administered for 5 
minutes through the Healer’s unique Energy Transmission 
process remotely to the test formulation under laboratory 
conditions. None of the Biofield Energy Healers in this 
study visited the laboratory in person, nor had any contact 
with the herbomineral samples. Further, the control group 
was treated with a “sham” healer for comparative purpose. 
The sham healer did not have any knowledge about the 
Biofield Energy Treatment. After that, the Biofield Energy 
treated and untreated samples were kept in similar sealed 
conditions and used for identification of immunological 
biomarkers. 
2.4. Antigen (Sheep RBC) 
The fresh sheep blood was collected aseptically from the 
jugular vein of a healthy sheep and transferred immediately 
to the heparinized tube. The collected erythrocytes were 
separated from plasma by centrifugation (400 g, 10°C, 10 
minutes), washed twice with the normal saline and then 
further diluted in saline, which were analyzed using a 
Hematology analyzer (Abbott Model-CD-3700). Based on 
the number of erythrocytes, the samples were further diluted 
(using saline) before injecting to the rats [34]. 
2.5. Experimental Procedure 
After seven days of acclimatization, the animals were 
grouped based on the body weight. A total of seven groups 
(G) were included i.e. G1 to G7 with eight animals (n=8) in 
each group. The animals were received cyclophosphamide 
in all the groups except G1 at a dose of 10 mg/kg in normal 
saline through intraperitoneal (i.p.) route 1 hour before 
administration of the test formulation, from day 1 to 13. 
However, G1, G2, and G6 group’s animals were 
administered with vehicle (0.5% carboxy methyl cellulose-
sodium salt) via oral gavage. G3 group animals received 
reference item, levamisole at a dose of 75 mg/kg body 
weight. G4 group animals received Biofield Energy Treated 
test formulation at 1105.005 mg/kg b.wt, (per oral) p.o. and 
G5 animals received the untreated test formulation at the 
same dose by oral route. Further, G6 group animals 
received Biofield Energy Treatment per se at day -15, 
without test formulation, while G7 group animals received 
Biofield Energy Treated test formulation at day -15. The 
freshly prepared suspensions of the Biofield Energy Treated 
and untreated test formulations were administered orally to 
the G4 and G5 groups, respectively at a dose of 1105.005 
mg/kg from day 1 to day 25. However, Biofield Energy 
Treated test formulation was administered orally to the G7 
group at same dose from day -15 to day 25. The treatment 
was continued to all the tested groups (G1 to G7) with 5 
mL/kg body weight dose volume. 
However, all the animals (G1-G7) were challenged with 
sheep red blood cells (sRBC) (0.5 x 10
9
/100 gm; i.p.) on 
day 7 and 13, as the antigenic material to sensitize them for 
immunological studies. On day 13
th
 and 20
th
 the animals 
were bled and the samples were subjected to 
hemagglutination test for cellular (CD4
+
 and CD8
+
) and 
humoral (IgG and IgM) immune responses. On same day 
20
th
, the animals were challenged with sRBC (0.5 x 10
9
 
cells/50µL/rat) in sub-planter region and on day 21
st
 (24 
hours) paw volume was measured to evaluate the cellular 
immune response. The body weight and food consumption 
were measured daily before treatment. The animals were 
kept on overnight fasting on day 24, followed by blood 
collection from retro-orbital plexus under isoflurane 
anaesthesia and the samples were subjected for 
haematology analysis, serum for biochemistry and hormone 
estimation. A portion of liver samples were snap frozen and 
stored in -80°C for the estimation of anti-oxidant 
parameters (SOD, Catalase, and LPO). At the end of the 
study, animals were euthanized by CO2 asphyxiation as per 
in-house approved standard protocol. Different organs of all 
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animals were excised, weighed and preserved for 
histopathological analysis. 
2.6. Assessment of Cellular and Humoral Responses 
Humoral immune response, IgG and IgM were estimated 
using Mini Vidas, Biomeurix (French) from serum, using 
commercially available kits. The flow cytometry was used to 
evaluate the CD4
+
 and CD8
+
 cells in blood as a measure of 
the cellular immune response. The mean value was 
calculated for each group with SEM. The percent change in 
the Biofield Energy Treated group was calculated compared 
to the vehicle treatment group. 
2.7. Assessment of Hematology Parameters 
Hematological parameters such as total leukocyte count 
(TLC), and differential leukocyte counts (DLC), were 
analyzed using a Hematology analyzer (Abbott Model-CD-
3700) in blood samples. 
2.8. Assessment of Lipid Profile and Hepatic Enzymes 
Glucose, total cholesterol (TC), triglycerides (TG), low 
density lipoprotein (LDL), high density lipoprotein (HDL), 
very low density lipoprotein (VLDL), alkaline phosphatase 
(ALP), serum glutamic oxaloacetic transaminase (SGOT), 
and serum glutamate-pyruvate transaminase (SGPT) were 
analyzed using serum [35, 36]. 
2.9. Assessment of Sex Hormone - Testosterone 
The level of testosterone was analyzed in serum using 
commercial kits. The mean value was calculated for each 
group with SEM. The percent change in the treated group 
was calculated compared to the vehicle treatment group. 
 
2.10. Assessment of Antioxidant Profile by ELISA Assay 
Superoxide dismutase (SOD), catalase and lipid 
peroxidase (LPO) were analyzed by ELISA assay using liver 
homogenate sample [37-39]. 
2.11. Statistical Analysis 
All the results were expressed as mean ± standard error of 
mean (SEM) and subjected to statistical analysis using Sigma 
Plot (Version 11.0). Student’s t-test was performed for 
comparison of the individual treatment group with control. 
The p≤0.05 was considered as statistically significant. 
3. Results and Discussion 
3.1. Measurement of Humoral Immune Response 
The effects of the Biofield Energy Treated and untreated 
test formulations on immunoglobulin levels (IgG and IgM) 
are demonstrated in the Figure 1. IgG and IgM are the major 
immunoglobulin that are considered as important role in 
complement activation, opsonization, neutralization of 
toxins, etc. There was a slight increased level of IgG in the 
Biofield Energy Treated test formulation group (G4) when 
compared to the disease control group (G2). The level of IgM 
in all the tested groups were decreased as compared to the 
disease control group. The level of IgM in the Biofield 
Energy Treated test formulation, and Biofield Energy 
Treatment per se (G6) group showed slight decreased by 
4.76% and 9.52%, respectively compared with the disease 
control. However, the IgG level was significantly increased 
by 2.89%, 6.20%, and 6.20% in the Biofield Energy Treated 
test formulation, Biofield Energy Treatment per se (day -15), 
and Biofield Energy Treated test formulation (day -15), 
respectively compared with the disease control. 
 
Figure 1. The effect of the test formulation on immunoglobulins, A. IgM and B. IgG after treatment on various groups (G1 - G7) in male SD rats. G1: Normal 
control; G2: Disease control; G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: Biofield Energy Treatment 
per se at day -15 (without test formulation); and G7: Biofield Energy Treated test formulation at day -15. All the values are represented as mean ± SEM (n=8). 
Overall, the levels of IgM and IgG in the Biofield Energy 
Treated test formulation group were altered, however the IgG 
response was significantly elevated and showed better 
response compared with the IgM. However, Biofield Energy 
Treated test formulation showed improved level of IgG 
compared with the untreated test formulation. The literature 
suggest that the components of test formulation, i.e. 
ashwagandha root extract and the minerals like zinc, 
selenium, and magnesium have reported with an improved 
immunoglobulin production [40, 41]. Thus, the study results 
showed that the IgG level was significantly increased with 
the Biofield Energy Treated test formulation (G4) and 
Biofield Energy Treatment per se (G6) with significant effect 
compared with the disease control group. 
0.00
0.05
0.10
0.15
0.20
0.25
G1 G2 G3 G4 G5 G6 G7
Ig
M
 (
m
g
/m
L
)
A
0.00
0.50
1.00
1.50
2.00
2.50
3.00
G1 G2 G3 G4 G5 G6 G7
Ig
G
 (
m
g
/m
L
)
B
 Advances in Bioscience and Bioengineering 2017; 5(6): 96-106 100 
 
3.2. Measurement of Cellular Responses 
The effects of the Biofield Energy Treated and untreated 
test formulations on ratio of CD4
+
/CD8
+
 in male SD rats are 
demonstrated in Figure 2. The CD markers i.e. the 
concentrations of CD4
+
 and CD8
+
 were analyzed using 
whole blood. The ratio of CD4
+
/CD8
+
 in normal control 
(G1), disease control (G2), levamisole (G3), Biofield Energy 
Treated test formulation (G4), untreated test formulation 
(G5), Biofield Treatment per se (day -15) (G6), and Biofield 
Energy Treated test formulation (day -15) (G7) were 1.56, 
1.05, 1.16, 1.09, 1.15, 1.18, and 1.22, respectively. Overall, 
the experimental results suggests that the CD4
+
/CD8
+
 ratio 
was increased by 3.80%, 12.38%, and 16.19% in the G4, G6, 
and G7, respectively compared with the disease control (G2). 
 
Figure 2. The effect of the test formulation on the ratio of cellular biomarkers (CD4+/CD8+ ration) after treatment on various groups (G1 - G7) in male SD 
rats. G1: Normal control; G2: Disease control; G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: Biofield 
Energy Treatment per se at day -15 (without test formulation); and G7: Biofield Energy Treated test formulation at day -15. All the values are represented as 
mean ± SEM (n=8). 
Lymphocyte populations are categorized as T, B, and 
natural killer cells, while its subpopulations is categorized as 
CD4
+
 and CD8
+
. Lymphocytes, a category of white blood 
cell in the immune system, which reflects the immune 
strength. It is regarded that CD4
+
 cells can protect and fight 
against infections, while CD8
+
 cells have the capacity to kill 
cancer cells and other invaders. The ratio of CD4
+
/CD8
+
 
reflects the health of immune system and the normal ratio is 
suggested as 2. If the ratio is higher, it suggests that the 
immune system is stronger as compared with the low ratio of 
CD4
+
/CD8
+
, which reflects infection [42, 43]. The 
experimental results suggests that the Biofield Energy 
Treated test formulation improved the CD4
+
/CD8
+ 
ratio by 
3.80%, but Biofield Energy Treatment per se group was 
increased by 12.38%. This suggests that The Trivedi Effect
®
 
per se and Biofield Energy Treated test formulation (day -15) 
groups have the significant capacity to do change in the 
immune system, and modulate the overall immune function, 
which can be used against inflammatory disorders, 
autoimmune diseases, antiaging, and for stress management 
and prevention. 
3.3. Assessment of Hematology Parameters 
The hematology parameters such as total and differential 
leucocytes counts of different groups (G1 to G7) are 
summarized in the Table 1. The results suggest the animal 
hematology profile after administration of the Biofield 
Energy Treated and untreated test formulations were 
significantly improved compared with the disease control 
group. Hematology parameters such as TLC, neutrophils, 
lymphocytes, eosinophils, and monocytes showed an altered 
profile such as decreased lymphocyte and monocytes count 
by 0.76% and 2.10%, respectively in the Biofield Energy 
Treated test formulation group (G4) compared with the 
disease control group (G2). TLC and neutrophil levels were 
increased by 9.64% and 1.48%, respectively in the G4 group 
compared with the G2. Besides, Biofield Energy Treatment 
per se (without test formulation) group (G6) showed an 
increase in TLC, lymphocytes, and monocytes count by 
19.79%, 2.87%, and 15.54%, compared with the disease 
control. Similarly, an improved patterns was also observed in 
case of Biofield Energy Treated test formulation (day -15) 
group (G7), such as increased TLC, lymphocytes, 
eosinophils, and monocytes counts by 51.26%, 3.50%, 
7.43%, and 36.55%, respectively with respect to the disease 
control group. However, a slight increase in the count was 
also reported in case of neutrophils and eosinophils by 1.48% 
and 4.57%, respectively in G4 compared with the disease 
control. 
The data suggest the Biofield Energy Treated test 
formulation (G4) and Biofield Energy Treatment per se (G6) 
improved the concentration of eosinophils, as they play a 
major and beneficial role as a modulatory element. A report 
showed that an increased number of eosinophils was directly 
related with the multifunctional aspect such as diverse 
inflammatory and physiologic immune responses [44]. Thus, 
an improved number of eosinophil after treatment might 
regulate the immune system and can be useful against many 
autoimmune disorders. 
However, various reports suggested an improved 
hematological parameters after administration of different 
herbal extracts like ashwagandha [45], Afzelia africana [46], 
etc. Besides, the important minerals were widely reported to 
improve the hematological profile that could improve the 
immunity, such as zinc [47], selenium [48], and magnesium 
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[49], which were reported with a significant improved 
biochemical profile. The test herbomineral formulations, is 
the combination of the herbal extract and minerals, which 
might be responsible for improving the hematological profile 
of male SD rats, as matched with the existing literature. 
However, the Biofield Energy Treatment further an improved 
the action of test formulation and showed significant changes 
with respect to the untreated test formulation. Thus, it can be 
assumed that Biofield Energy Treatment per se (The Trivedi 
Effect
®
) has the capacity to improve the immunomodulatory 
potential of test formulation by improving the hematological 
profile. 
Table 1. Hematology profile of male Sprague Dawley rats after administration of test formulation. 
Group (G) TLC (thousand/mm3) Neutrophils (%) Lymphocytes (%) Eosinophils (%) Monocyte (%) 
1 10.18 ± 0.74 18.38 ± 2.00 78.25 ± 2.15 1.50 ± 0.19 1.88 ± 0.23 
2 5.91 ± 0.31 30.38 ± 2.36 65.50 ± 2.51 1.75 ± 0.25 2.38 ± 0.26 
3 8.74 ± 0.40 35.25 ± 2.28 59.00 ± 2.61 1.63 ± 0.18 4.13 ± 0.81 
4 6.48 ± 0.51 30.83 ± 2.33 65.00 ± 2.37 1.83 ± 0.31 2.33 ± 0.21 
5 7.14 ± 0.69 31.25 ± 2.23 64.75 ± 2.40 1.50 ± 0.19 2.50 ± 0.19 
6 7.08 ± 0.62 28.38 ± 1.28 67.38 ± 1.43 1.50 ± 0.19 2.75 ± 0.16 
7 8.94 ± 0.68*** 27.38 ± 2.37 67.50 ± 2.88 1.88 ± 0.23 3.25 ± 0.86 
G: Group; G1: Normal control; G2: Disease control; G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: 
Biofield Energy Treatment per se at day -15 (without test formulation); and G7: Biofield Energy Treated test formulation at day -15. All the values are 
represented as mean ± SEM (n=8). TLC: Total leukocyte count; %: Percentage, ***p≤0.001 (compared to the disease control). 
3.4. Measurement of Glucose and Lipid Biomarkers 
The results of biochemical parameters such as glucose, 
total cholesterol (TC), triglycerides (TG), high density 
lipoprotein (HDL), low density lipoprotein (LDL), and very 
low density lipoprotein (VLDL) of different groups (G1 to 
G7) are summarized in the Table 2. The results showed the 
concentration of glucose was increased by 11.78%, 18.60%, 
and 56.84% in the G4, G6, and G7 group, respectively 
compared with the disease control group. The level of 
triglycerides was significantly decreased in the Biofield 
Energy Treated test formulation (G4) and Biofield Energy 
Treated test formulation, day -15 (G7), by 10.54% and 
4.20%, respectively compared with the disease control. 
However, Biofield Energy Treatment per se (G6) increased 
the TC concentration by 11.59% compared with the disease 
control. The level of triglycerides was increased in all the 
group with respect to disease control, like increased 
percentage by 24.44%, 35.80%, and 22.27% in G4, G6, and 
G7 group, respectively compared with the G2. However, the 
level of HDL was improved in the Biofield Energy Treatment 
per se (day -15) group (G6) and G7 by 11.69% and 1.06%, 
respectively as compared with the G2. Similarly, the LDL 
level was significantly decreased by 10.52% in the Biofield 
Energy Treated test formulation (G4) compared with the G2. 
Although, VLDL level was increased in all the groups, i.e. by 
24.31%, 35.80%, and 22.34% in the G4, G6, and G7 groups, 
respectively compared with the G2. 
Overall, the Biofield Energy Treated test formulation and 
Biofield Energy Treatment per se were observed with the 
beneficial effect on animal lipid profile. Scientific literature 
reported that herbal extract such as ashwagandha along with 
minerals like selenium, zinc, and magnesium have a 
significant effect on lipid profile, serum cholesterol, LDL, 
HDL, etc. with no clinical adverse effects [50-54]. Thus, it 
can be assumed that the altered lipid profile was due to the 
constituents present in the herbomineral formulation, but 
Biofield Energy Treated test formulation and Biofield Energy 
Treatment per se showed a significant improved lipid profile 
as compared with the untreated test formulation. It suggest 
that the Biofield Energy Treatment significantly improved 
the immunomodulatory activity by altering the lipid profile, 
which would be helpful against many autoimmune and anti-
inflammatory disorders. 
Table 2. Lipid profile analysis after treatment with the test formulation on male rats. 
Group (G) Glucose (mg/dL) TC (mg/dL) Triglyceride mg/dL) HDL (mg/dL) LDL (mg/dL) VLDL (mg/dL) 
1 131.15 ± 8.78 84.18 ± 3.52 73.11 ± 7.99 25.25 ± 1.06 44.79 ± 2.26 14.62 ± 1.60 
2 110.90 ± 5.70 92.85 ± 7.57 63.54 ± 9.78 27.81 ± 2.27 52.28 ± 3.95 12.71 ± 1.96 
3 122.49 ± 8.31 111.25 ± 13.25 99.56 ± 9.18 33.35 ± 3.97 59.66 ± 7.74 19.91 ± 1.84 
4 123.96 ± 10.98 89.40 ± 6.42 79.07 ± 9.06 26.82 ± 1.92 46.78 ± 4.76 15.80 ± 1.81 
5 131.09 ± 7.18 83.06 ± 3.49 74.06 ± 6.52 24.89 ± 1.05 43.30 ± 1.64 14.81 ± 1.30 
6 131.53 ± 8.62 103.58 ± 3.57 86.29 ± 4.55 31.06 ± 1.07 55.24 ± 2.68 17.26 ± 0.91 
7 173.94 ± 15.20** 88.95 ± 5.71 77.69 ± 10.14 28.09 ± 2.44 54.03 ± 3.86 15.55 ± 2.02 
G: Group; G1: Normal control; G2: Disease control; G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: 
Biofield Energy Treatment per se at day -15 (without test formulation); and G7: Biofield Energy Treated test formulation at day -15. All the values are 
represented as mean ± SEM (n=8). TC: Total Cholesterol; HDL: High density lipoprotein; LDL: Low density lipoprotein; VLDL: Very low density 
lipoprotein; mg/dL: Milligram per deciliter; **p≤0.01 (compared to the disease control). 
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3.5. Measurement of Hepatic and Cardiac Biomarkers 
The biochemical parameters i.e. hepatic enzymes like 
serum glutamate oxaloacetate transaminase (SGOT), serum 
glutamate pyruvate transaminase (SGOT), alkaline 
phosphatase (ALP) and cardiac enzyme creatine kinase 
myocardium band (CK-MB), and others biomarkers such as, 
total bilirubin, albumin, and globulin in different groups (G1 
to G7) were evaluated and are shown in the Table 3. The 
level of SGOT, CK-MB, TP, A, and G were significantly 
decreased by 4.04%, 23.54%, 1.68%, 1.54%, and 1.80%, 
respectively in the Biofield Energy Treated test formulation 
(G4) compared with the disease control (G2). However, the 
Biofield Energy Treatment per se group (G6) also showed a 
decreased level of SGOT, CK-MB, and A/G ratio by 2.08%, 
16.23%, and 3.40%, respectively compared with the disease 
control (G2). However, SGOT level was significantly 
(
**
p≤0.01) decreased by 18.88% in the G7 group compared 
with the G2 group. The other tested parameters were slightly 
increased in all the treated group compared to the disease 
control group such as total bilirubin, total protein, albumin, 
and globulin. However, the change was not significant in all 
the treated groups compared to the disease control (G2). 
Table 3. Evaluation of hepatic biomarkers after treatment with the test formulation on male rats. 
Group 
(G) 
TB (mg/dL) SGOT (U/L) SGPT (U/L) ALP (U/L) CK-MB (U/L) TP (g/dL) A (g/dL) G (g/dL) A/G ratio 
1 0.14 ± 0.01 230.21 ± 7.55 43.69 ± 1.82 201.14 ± 15.47 1198.80 ± 66.80 8.40 ± 0.11 3.91 ± 0.03 4.49 ± 0.08 0.87 ± 0.01 
2 0.11 ± 0.01 201.94 ± 10.09 40.01 ± 2.16 176.16 ± 7.33 1030.79 ± 67.87 8.32 ± 0.05 3.88 ± 0.04 4.44 ± 0.03 0.88 ± 0.01 
3 0.17 ± 0.02 201.49 ± 9.01 49.44 ± 4.77 216.84 ± 13.36 803.56 ± 70.55 8.36 ± 0.18 3.89 ± 0.06 4.47 ± 0.13 0.87 ± 0.01 
4 0.14 ± 0.02 193.77 ± 17.37 44.37 ± 7.28 180.93 ± 7.34 788.12 ± 91.52 8.18 ± 0.16 3.82 ± 0.04 4.36 ± 0.17 0.88 ± 0.04 
5 0.12 ± 0.01 183.43 ± 13.13 35.78 ± 2.16 217.33 ± 14.81 663.34 ± 77.16 8.38 ± 0.10 3.93 ± 0.03 4.44 ± 0.09 0.89 ± 0.02 
6 0.12 ± 0.01 197.73 ± 13.71 47.54 ± 2.91 291.18 ± 11.38 863.41 ± 83.00 8.59 ± 0.10 3.93 ± 0.04 4.65 ± 0.08 0.85 ± 0.01 
7 0.13 ± 0.02 163.81 ± 11.71* 40.61 ± 2.52 264.43 ± 10.77 624.38 ± 84.02** 8.54 ± 0.14 3.91 ± 0.06 4.63 ± 0.11 0.85 ± 0.02 
G: Group; G1: Normal control; G2: Disease control; G3: Levamisole; G4: Biofield Energy Treated test formulation; G5: Untreated test formulation; G6: 
Biofield Energy Treatment per se at day -15 (without test formulation); and G7: Biofield Energy Treated test formulation at day -15. All the values are 
represented as mean ± SEM (n=8). SGOT: Serum glutamic oxaloacetic transaminase; SGPT: Serum glutamate-pyruvate transaminase; ALP: Alkaline 
phosphatase; CK-MB: Creatine kinase-myocardial band; TB: Total bilirubin; TP: Total protein; A: Albumin; G: Globulin; A/G: Albumin/Globulin ratio; U/L: 
Unit per liter; mg/dL: Milligram per deciliter, *p≤0.05 and **p≤0.01 denoted as statistically significant compared to the disease control. 
The level of hepatic biomarkers in the disease control 
group (G2) was significantly increased, which suggest liver 
toxicity according to the data of TB, SGOT, SGPT, ALP, TP, 
CK-MB, albumin, and globulin as compared with the normal 
control (G1). Further, the data showed Biofield Energy 
Treated test formulation and Biofield Energy Treatment per 
se groups protect the hepatic liver enzymes, with a significant 
decreased amount of SGOT, ALP, CK-MB, TP, A, G, and 
A/G ratio. These enzymes are the biomarkers for liver 
toxicity and suggests liver damage [55]. The herbomineral 
formulation and its individual components are reported to 
have beneficial effect to protection the hepatic biomarkers. 
Ashwagandha was reported to have significant effect on 
hepatic enzymes, while minerals such as selenium, zinc, and 
magnesium have been reported with a significant effect on 
liver biomarkers [56-59]. Thus, it can be concluded that 
Biofield Energy Treatment per se and Biofield Energy 
Treated test formulation could protect the liver toxicity and 
could help in regulating the immune function by altering the 
level of hepatic biomarkers. 
3.6. Measurement of Sex Hormone 
The effects of the Biofield Energy Treated and untreated 
test formulations on the level of sex hormone, testosterone in 
male SD rats are shown in the Figure 3. Serum testosterone 
level was significantly altered in all the tested groups. The 
level of testosterone (in ng/dL) in disease control (G2), 
levamisole (G3), Biofield Energy Treated test formulation 
(G4), untreated test formulation (G5), Biofield Energy 
Treatment per se (G6) and Biofield Energy Treated test 
formulation, day -15 (G7) were 137.0 ± 36.37, 235.75 ± 
105.72, 32.00 ± 9.11, 177.43 ± 72.40, 111.75 ± 52.18, and 
76.63 ± 28.45 ng/dL, respectively. Overall, the level of 
testosterone was decreased by 76.67%, 18.43%, and 44.06% 
in the G4, G6, and G7 groups, respectively compared with 
the disease control group. 
The literature data suggests that all the individual 
constituents of test formulation have a significant effect on 
testosterone level. Individually, ashwagandha and the 
minerals were reported to have a significant effect in altering 
the testosterone level [60-62]. The literature also suggests the 
ameliorative potential of sodium selenite and zinc sulfate on 
intensive-swimming-induced testicular disorders, which 
reported significantly role of selenium and zinc in decreasing 
the plasma level of testosterone in mature male rats [63]. The 
study results showed a significant effect of the Biofield 
Energy Treated test formulation supplementation on 
testosterone level, thus it can be assumed that Biofield 
Energy Treatment has the significant capacity to alter the sex 
hormones. 
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Figure 3. The effect of the test formulation on the level of testosterone. G: Group; G1: Normal control; G2: Disease control; G3: Levamisole; G4: Biofield 
Energy Treated test formulation; G5: Untreated test formulation; G6: Biofield Energy Treatment per se at day -15 (without test formulation); and G7: Biofield 
Energy Treated test formulation at day -15. All the values are represented as mean ± SEM (n=8). **p≤0.01 compared to the disease control. 
3.7. Measurement of Antioxidant Profile by ELISA 
The effects of the Biofield Energy Treated and untreated 
test formulations on levels of various antioxidant enzymes 
such as SOD, LPO, and CAT in male SD rats are 
demonstrated in Figure 4. The antioxidant biomarkers such 
as SOD, LPO, and CAT were evaluated in liver samples. The 
LPO level in G4 and G6 was increased by 18.88% and 
3.33%, respectively compared with the G2, while in other 
groups the LPO level was decreased by 59.63% in G7 group. 
However, the SOD level in G4, G6, and G7 was significantly 
decreased by 57.23%, 59.03%, and 49.60%, respectively 
compared with the G2 group. Similarly, decreased pattern of 
catalase (CAT) activity was reported by 42.26%, 48.35%, and 
57.64% in G4, G6, and G7, respectively compared with the 
G2 group. Overall, the LPO level was significantly decreased 
by 59.63% in the Biofield Energy Treated test formulation 
(day -15), while the level of antioxidants were significantly 
decreased. Scientific reports suggest that decreased level of 
free radicles can be beneficial against many inflammatory 
diseases [64]. This suggests that Biofield Energy Treatment 
has the significant capacity to minimize the level of free 
radicles, which can be helpful to modulate the immune 
system against several inflammatory and autoimmune 
diseases. 
 
Figure 4. The effect of the test formulation on anti-oxidative markers (A). LPO, (B). SOD, and (C). Catalase after treatment in male SD rats. All the values are 
represented as mean ± SEM (n=8); *p≤0.05, **p≤0.01 and ***p≤0.001 (compared to the disease control). 
4. Conclusions 
Based on the current findings and the results of the 
immune biomarkers assay after oral administration of 
herbomineral formulation exhibited significantly impact of 
The Trivedi Effect
®
- Energy of Consciousness Healing 
Treatment (Biofield Energy Healing Treatment) on animals 
and test formulation group, which showed a significant 
improved humoral and cellular immunity. In case of humoral 
immune response, the IgG level was significantly increased 
by 2.89%, 6.20%, and 6.20% in the Biofield Energy Treated 
test formulation (G4), Biofield Energy Treatment per se at 
day -15 (G6), and Biofield Energy Treated test formulation at 
day -15 (G7), respectively as compared with the disease 
control (G2). The ratio of CD4
+
/CD8
+
 as cellular immune 
response was increased in the G4, G6, and G7 groups by 
3.80%, 12.38%, and 16.19%, respectively compared with the 
G2 group. This increase in CD4
+
/CD8
+
 ratio suggest strong 
immune strength after Biofield Energy Healing. Besides, a 
significant improved hematological profile such as TLC and 
neutrophil was increased by 9.64% and 1.48%, respectively 
in the G4 group compared with disease control group (G2). 
However, Biofield Energy Treatment group per se (G7) also 
showed a significant increased levels of TLC, lymphocytes, 
and monocytes by 19.79%, 2.87%, and 15.54%, respectively 
compared with the disease control (G2). Similarly, the 
Biofield Energy Treated test formulation (day -15) (G7) 
group showed an improved level of TLC, lymphocytes, 
eosinophils, and monocytes by 51.26%, 3.50%, 7.43%, and 
36.55%, respectively compared with disease control group 
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(G2). In biochemical estimation, the level of total cholesterol 
was significantly decreased in the Biofield Energy Treated 
test formulation and Biofield Energy Treated test formulation 
at day -15 by 10.54% and 4.20%, respectively compared with 
the disease control. Similarly, HDL level was increased by 
11.69% in the Biofield Energy Treatment per se (day -15) 
group compared with the disease control group (G2). LDL 
level was significantly decreased by 10.52% in the Biofield 
Energy Treated test formulation (G4) compared with the 
disease control group (G2). Among hepatic biomarkers, 
SGOT, TP, A, and G levels were significantly decreased, 
while CK-MB level was decreased by 23.54% in the Biofield 
Energy Treated test formulation (G4) as compared with the 
disease control (G2). Besides, Biofield Energy Treatment per 
se group (G6) showed decrease in the values of SGOT, CK-
MB, and A/G by 2.08%, 16.23%, and 3.40%, respectively 
compared with the disease control. The level of testosterone 
was significantly altered in the Biofield Energy Treated test 
formulation compared with the disease control group. 
Antioxidant assay suggests that the free radical, LPO was 
significantly decreased by 59.63% in the Biofield Energy 
Treated test formulation at day -15 (G7) compared with the 
disease control, while antioxidants such as SOD and 
catalases were significantly altered after Biofield Energy 
Treatment to the test formulation compared with the disease 
control group. 
Overall, it can be concluded that the novel herbomineral 
formulation after treatment with the Trivedi Effect
®
-Biofield 
Energy Healing remotely by the seven Biofield Energy 
Healers enhanced the herbomineral test formulation’s anti-
inflammatory and immunomodulatory properties. Therefore, 
the Biofield Energy Treated test formulation may act as an 
effective anti-inflammatory and immunomodulatory product, 
and it can be used as a Complementary and Alternative 
Medicine (CAM) with a safe therapeutic index for various 
autoimmune disorders such as Lupus, Systemic Lupus 
Erythematosus, Fibromyalgia, Addison Disease, Hashimoto 
Thyroiditis, Celiac Disease (gluten-sensitive enteropathy), 
Multiple Sclerosis, Dermatomyositis, Graves’ Disease, 
Myasthenia Gravis, Pernicious Anemia, Aplastic Anemia, 
Scleroderma, Psoriasis, Rheumatoid Arthritis, Reactive 
Arthritis, Type 1 Diabetes, Sjogren Syndrome, Crohn’s 
Disease, Vasculitis, Vitiligo, Chronic Fatigue Syndrome and 
Alopecia Areata, as well as inflammatory disorders such as 
Irritable Bowel Syndrome (IBS), Asthma, Ulcerative Colitis, 
Alzheimer’s Disease, Parkinson’s Disease, Atherosclerosis, 
Dermatitis, Hepatitis, and Diverticulitis. Further, the Biofield 
Energy Healing Treated test formulation can also be used in 
the prevention of immune-mediated tissue damage in cases of 
organ transplants (for example heart transplants, kidney 
transplants and liver transplants), for anti-aging, stress 
prevention and management, and in the improvement of 
overall health and quality of life. 
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